Lv1
80 积分 2023-02-28 加入
First 23-Patient Safety and Efficacy Data from Nexicart-2, the First U.S. Trial of CAR-T in R/R Light Chain (AL) Amyloidosis, Nxc-201
17天前
已关闭
Arlocabtagene Autoleucel, a GPRC5D-Targeted CAR T-Cell Therapy for Patients With Relapsed/Refractory Multiple Myeloma: Updated Phase 1 Safety and Efficacy Results in Patients With 1–3 Prior Regimens
1个月前
已关闭
International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma
5个月前
已完结
Imaging in Multiple Myeloma - Independent review perspective for IMWG 2016 response assessment
5个月前
已完结
Extramedullary multiple myeloma
9个月前
已完结
皖公网安备34019202002308